Chlamydia trachomatis virulence factor CT135 is stable in vivo but highly polymorphic in vitro

Pathogens and Disease

Volumn 73, Issue 6, 2015, Pages

  Bonner, Christine ^a   Caldwell, Harlan D ^b   Carlson, John H ^b   Graham, Morag R ^a   Kari, Laszlo ^b   Sturdevant, Gail L ^b   Tyler, Shaun ^a   Zetner, Adrian ^a   McClarty, Grant ^a,c  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Department of Medical Microbiology ^*  (Canada)

Author keywords

Chlamydia trachomatis; CT135; Deep sequencing; Genomics; Single nucleotide polymorphism; Virulence factor

Indexed keywords

BACTERIAL PROTEIN; CHLAMYDIA TRACHOMATIS VIRULENCE FACTOR CT134; CHLAMYDIA TRACHOMATIS VIRULENCE FACTOR CT135; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL DNA;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; CONTROLLED STUDY; GENE DISRUPTION; GENE LOCUS; GENETIC VARIATION; IN VITRO STUDY; IN VIVO STUDY; NEXT GENERATION SEQUENCING; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; PROTEIN STABILITY; SEROTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; ANIMAL; CHLAMYDIASIS; DNA SEQUENCE; GENE DELETION; GENETIC SELECTION; GENETICS; GENOMIC INSTABILITY; HIGH THROUGHPUT SEQUENCING; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOUSE; MUTATION; PATHOGENICITY; VIRUS CULTURE;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DNA, BACTERIAL; GENE DELETION; GENETIC VARIATION; GENOMIC INSTABILITY; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MICE; MUTATION; SELECTION, GENETIC; SEQUENCE ANALYSIS, DNA; SERIAL PASSAGE; VIRULENCE FACTORS;

EID: 85014123895     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftv043     Document Type: Article

References (20)

1. Albrecht M, Sharma CM, Reinhardt R, et al. Deep sequencingbased discovery of the Chlamydia trachomatis transcriptome. Nucleic Acids Res 2010;38:868-77.
2. Bachmann NL, Polkinghorne A, Timms P. Chlamydia genomics: providing novel insights into chlamydial biology. Trends Microbiol 2014;22:464-72.
3. Blankenberg D, Von Kuster G, Bouvier E, et al., Dissemination of scientific software with Galaxy ToolShed. Genome Biol 2014;15:403.
4. Caldwell HD, Wood H, Crane D, et al. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest 2003;111: 1757-69.
5. Carlson JH, Hughes S, Hogan D, et al. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect Immun 2004;72:7063-72.
6. Chen C, Zhou Z, Conrad T, et al. In vitro passage selects for Chlamydia muridarum with enhanced infectivity in cultured cells but attenuated pathogenicity in mouse upper genital tract. Infect Immun 2015;83:1881-92.
7. Dehoux P, Flores R, Dauga C, et al. Multi-genome identification and characterization of chlamydiae-specific type III secretion substrates: the Inc proteins. BMC Genomics 2011; 12:109.
8. Jasper DK, Sigar IM, Schripsema JH, et al. Genomic variant representation in a Chlamydia population is dynamic and adaptive with dependence on in vitro and in vivo passage. Pathog Dis 2015;73:1-12.
9. Johnson CM, Fisher DJ. Site-specific, insertional inactivation of incA in Chlamydia trachomatis using a group II intron. PLoS One 2013;8:e83989.
10. Kari L, Whitmire WM, Olivares-Zavaleta N, et al. A liveattenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med 2011;208: 2217-23.
11. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012;9:357-9.
12. Lutter EI, Martens C, Hackstadt T. Evolution and conservation of predicted inclusion membrane proteins in chlamydiae. Comp Funct Genomics 2012;2012:362104.
13. Morrison RP, Caldwell HD. Immunity tomurine chlamydial genital infection. Infect Immun 2002;70:2741-51.
14. Ramsey KH, Sigar IM, Schripsema JH, et al. Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect Immun 2009;77:3284-93.
15. Read TD, Brunham RC, Shen C, et al. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39. Nucleic Acids Res 2000;28:1397-406.
16. Song L, Carlson JH, Whitmire WM, et al. The Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence associated genes. Infect Immun 2013;81:636-44.
17. Stephens RS, Kalman S, Lammel C, et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998;282:754-9.
18. Sturdevant GL, Kari L, Gardner DJ, et al. Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Infect Immun 2010;78:3660-8.
19. Thomson NR, Holden MT, Carder C, et al. Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome Res 2008;18:161-71.
20. Wang Y, Kahane S, Cutcliffe LT, et al. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog 2011;7:e1002258.